Standout Papers

Rosuvastatin to Prevent Vascular Events in Men and Women with E... 1999 2026 2008 2017 4.6k
  1. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (2008)
    Paul M. Ridker, Eleanor Danielson et al. New England Journal of Medicine
  2. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein (2009)
    Paul M. Ridker, Eleanor Danielson et al. Obstetrical & Gynecological Survey
  3. The Metabolic Syndrome and Cardiovascular Risk (2010)
    Salvatore Mottillo, Kristian B. Filion et al. Journal of the American College of Cardiology
  4. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009)
    Paul M. Ridker, Eleanor Danielson et al. The Lancet
  5. Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence (1999)
    John W. Eikelboom, Eva Lonn et al. Annals of Internal Medicine
  6. The Heart and the Atrial Natriuretic Factor* (1985)
    M. Cantin, Jacques Genest Endocrine Reviews
  7. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism (2009)
    Robert J. Glynn, Eleanor Danielson et al. New England Journal of Medicine
  8. Familial lipoprotein disorders in patients with premature coronary artery disease. (1992)
    Jacques Genest, Sarah Martin-Munley et al. Circulation
  9. Low density lipoprotein particle size and coronary artery disease. (1992)
    Hannia Campos, Jacques Genest et al. Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  10. NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS. (1964)
    R. Boucher, R Veyrat et al. PubMed
  11. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions (2018)
    Paolo Raggi, Jacques Genest et al. Atherosclerosis
  12. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease (2020)
    Pengwei Hu, Kanika Dharmayat et al. Circulation

Immediate Impact

20 by Nobel laureates 52 from Science/Nature 86 standout
Sub-graph 1 of 16

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
2019 Standout
2 intermediate papers

Works of Jacques Genest being referenced

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
2013
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Jacques Genest 15748 10316 12801 704 39.5k
Steve E. Humphries 13992 9792 9743 860 41.5k
J. Wouter Jukema 16605 6162 12798 881 36.4k
Erik S.G. Stroes 13344 6575 7919 490 28.5k
Antonio M. Gotto 26174 16038 11477 588 48.9k
James T. Willerson 16670 3951 20757 628 47.0k
Julie E. Buring 10564 12151 15309 596 64.0k
Anne Tybjærg‐Hansen 10644 9027 7161 341 27.4k
Stephen J. Nicholls 16519 8730 8452 663 29.2k
Alberico L. Catapano 14340 8163 7003 628 28.9k
Anders Hamsten 6327 8095 7767 386 29.7k

All Works

Loading papers...

Rankless by CCL
2026